Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000919574-25-005609
Filing Date
2025-09-09
Accepted
2025-09-09 12:58:26
Documents
3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 11462
2 d11981011_ex99-a.htm EX-99 6128
3 d11981011_ex99-b.htm EX-99 1011
  Complete submission text file 0000919574-25-005609.txt   20588
Mailing Address 152 WEST 57TH STREET 50TH FLOOR NEW YORK NY 10019
Business Address 152 WEST 57TH STREET 50TH FLOOR NEW YORK NY 10019 212-333-0100
KINGDON CAPITAL MANAGEMENT, L.L.C. (Filed by) CIK: 0001000097 (see all company filings)

EIN.: 134015739 | State of Incorp.: DE
Type: SCHEDULE 13G

Mailing Address 70 DOPPLER IRVINE CA 92618
Business Address 70 DOPPLER IRVINE CA 92618 949-261-2900
enVVeno Medical Corp (Subject) CIK: 0001661053 (see all company filings)

EIN.: 330936180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-90513 | Film No.: 251302524
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)